Follow
Rashan Haniffa
Rashan Haniffa
University of Edinburgh, University College Hospital London, KDU Hospital Sri Lanka, NICS-MORU
Verified email at ed.ac.uk
Title
Cited by
Cited by
Year
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ...
Medrxiv, 2021.01. 07.21249390, 2021
13322021
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP Investigators
New England Journal of Medicine 385 (9), 790-802, 2021
10382021
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ...
Jama 324 (13), 1317-1329, 2020
8262020
Interleukin-6 receptor antagonists in critically ill patients with Covid-19
Remap-Cap Investigators
New England Journal of Medicine 384 (16), 1491-1502, 2021
6102021
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
Jama 326 (6), 499-518, 2021
4742021
Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future
MJ Schultz, MW Dünser, AM Dondorp, NKJ Adhikari, S Iyer, A Kwizera, ...
Sepsis management in resource-limited settings, 1-24, 2019
2412019
Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low-and middle …
KE Rudd, CW Seymour, AR Aluisio, ME Augustin, DS Bagenda, A Beane, ...
Jama 319 (21), 2202-2211, 2018
2012018
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
1912021
Critical care bed capacity in Asian countries and regions
J Phua, MO Faruq, AP Kulkarni, IS Redjeki, K Detleuxay, N Mendsaikhan, ...
Critical care medicine 48 (5), 654-662, 2020
1842020
Recommendations for sepsis management in resource-limited settings
MW Dünser, E Festic, A Dondorp, N Kissoon, T Ganbat, A Kwizera, ...
Intensive care medicine 38, 557-574, 2012
1812012
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform …
S Bertagnolio, SS Thwin, R Silva, S Nagarajan, W Jassat, R Fowler, ...
The Lancet HIV 9 (7), e486-e495, 2022
1162022
Symptom burden in chronic kidney disease; a population based cross sectional study
S Senanayake, N Gunawardena, P Palihawadana, P Bandara, R Haniffa, ...
BMC nephrology 18, 1-8, 2017
992017
Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review
R Haniffa, I Isaam, AP De Silva, AM Dondorp, NF De Keizer
Critical care 22, 1-22, 2018
922018
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ...
Intensive care medicine 47, 867-886, 2021
882021
Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ...
Jama 329 (1), 39-51, 2023
842023
Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ...
Jama 327 (13), 1247, 2022
812022
Quality metrics for the evaluation of Rapid Response Systems: Proceedings from the third international consensus conference on Rapid Response Systems
CP Subbe, J Bannard-Smith, J Bunch, R Champunot, MA DeVita, ...
Resuscitation 141, 1-12, 2019
722019
Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational …
D Clark, A Joannides, AO Adeleye, AH Bajamal, T Bashford, H Biluts, ...
The Lancet Neurology 21 (5), 438-449, 2022
642022
Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial
REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ...
MedRxiv, 2021.06. 18.21259133, 2021
592021
Simplified prognostic model for critically ill patients in resource limited settings in South Asia
R Haniffa, M Mukaka, SB Munasinghe, AP De Silva, KSA Jayasinghe, ...
Critical Care 21, 1-8, 2017
582017
The system can't perform the operation now. Try again later.
Articles 1–20